The role of intestinal flora in metabolic dysfunction-associated steatotic liver disease and treatment strategies
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common multi-factorial liver disease, and its incidence is gradually increasing worldwide. Many reports have revealed that intestinal flora plays a crucial role for the occurrence and development of MASLD, through mechanisms such...
Saved in:
Main Authors: | Li Jun Wang, Jian Guang Sun, Shu Cheng Chen, Yu Li Sun, Yang Zheng, Jian Chao Feng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2024.1490929/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metabolic dysfunction-associated steatotic liver disease
by: Chieh Chen, et al.
Published: (2024-12-01) -
Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021
by: Gong Feng, et al.
Published: (2025-03-01) -
Steatotic Liver Disease: New Nomenclature and Its Localization in the Russian Federation
by: K. L. Raikhelson, et al.
Published: (2024-05-01) -
Retinopathy in Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Myrsini Orfanidou, et al.
Published: (2024-12-01) -
Correlation between family function and self-management abilities in patients with metabolic dysfunction-associated steatotic liver disease
by: Yueying Zhu, et al.
Published: (2025-01-01)